Patent For Therapeutic Skin Treatment Awarded to Topix Pharmaceuticals

Formulation contains sodium hyaluronate, an oligopeptide, antioxidants, Camellia sinensis leaf extract, resveratrol, ectoin and more.

Author Image

By: Christine Esposito

Editor-in-Chief

US Patent No. 11,433,006 B2 (Steven M. Hernandez); Topix Pharmaceuticals, Inc., North Amityville, NY, has been awarded a patent for a topical therapeutic treatment for skin in dermatological procedures. It is comprised of sodium hyaluronate; an oligopeptide (wherein the oligopeptide is 0.0001%-10% palmitoyl sh-tripeptide-4 amide on an active basis); one or more antioxidants (wherein the one or more antioxidants is between 0.1%-10% w/w and comprises one or more of Camellia sinensis leaf extract, ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters